Cargando…

The Prevalence and Risks of Inappropriate Combination of Aspirin and Warfarin in Clinical Practice: Results From WARFARIN-TR Study

BACKGROUND: The use of warfarin and aspirin in combination is restricted to limited patients under relevant guidelines. AIMS: To evaluate the prevalence of the inappropriate combination of aspirin and warfarin therapy in daily practice and its risks. STUDY DESIGN: Cross-sectional study. METHODS: The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kılıç, Salih, Çelik, Ahmet, Çekirdekçi, Elif, Altay, Servet, Elçik, Deniz, Akboğa, Mehmet Kadri, Durukan, Mine, Yayla, Çağrı, Zoghi, Mehdi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Galenos Publishing 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6335934/ https://www.ncbi.nlm.nih.gov/pubmed/30079702 http://dx.doi.org/10.4274/balkanmedj.2017.1472

Ejemplares similares

The awareness, efficacy, safety, and time in therapeutic range of warfarin in the Turkish population: WARFARIN-TR
por: Çelik, Ahmet, et al.
Publicado: (2016)

Inappropriate combination of warfarin and aspirin
por: Turan, Burak, et al.
Publicado: (2016)

The Time in Therapeutic Range and Bleeding Complications of Warfarin in Different Geographic Regions of Turkey: A Subgroup Analysis of WARFARIN-TR Study
por: Kılıç, Salih, et al.
Publicado: (2017)

Comparison of Warfarin use in terms of efficacy and safety in two different polyclinics
por: Kılıç, Salih, et al.
Publicado: (2017)

Effects of propolis on warfarin efficacy
por: Akbay, Esin, et al.
Publicado: (2017)

Point of care testing for improving risk- benefit ratio of aspirin and warfarin
por: Sheth, Harsh, et al.
Publicado: (2014)

Assessment of an Intervention to Reduce Aspirin Prescribing for Patients Receiving Warfarin for Anticoagulation
por: Schaefer, Jordan K., et al.
Publicado: (2022)

Long-Term Prognosis of Patients with Heart Failure: Follow-Up Results of Journey HF-TR Study Population
por: Şabanoğlu, Cengiz, et al.
Publicado: (2023)

Platelet to lymphocyte ratio: a novel and simple predictor of slow coronary flow
por: Akboğa, Mehmet Kadri, et al.
Publicado: (2016)

Endoscopic submucosal dissection for early gastric cancer without interruption of warfarin and aspirin
por: Tounou, Shigetaka, et al.
Publicado: (2015)

Warfarin overactivity
por: Yamanel, L, et al.
Publicado: (2005)

Warfarin and atrial fibrillation: from ideal to real the warfarin affaire
por: Molteni, Mauro, et al.
Publicado: (2014)

Warfarin-related nephropathy: possible role for the warfarin pharmacogenetic profile
por: Di Maso, Vittorio, et al.
Publicado: (2014)

Influence of Sampling on the Determination of Warfarin and Warfarin Alcohols in Oral Fluid
por: Lomonaco, Tommaso, et al.
Publicado: (2014)

Inappropriate preinjury warfarin use in trauma patients: A call for a safety initiative
por: HH, Hon, et al.
Publicado: (2016)

In Reply to Keskin and Orhan
por: Kılıç, Salih, et al.
Publicado: (2019)

Warfarin-related nephropathy in a patient with mild IgA nephropathy on dabigatran and aspirin
por: Moeckel, Gilbert W., et al.
Publicado: (2013)

Moxifloxacin-warfarin interaction
por: Ji, Yan, et al.
Publicado: (2012)

Warfarin-related Nephropathy
por: Golla, Anvesh, et al.
Publicado: (2018)

Nuclear receptor gene polymorphisms and warfarin dose requirements in the Quebec Warfarin Cohort
por: Shahabi, Payman, et al.
Publicado: (2018)

Neutrophil-to-lymphocyte ratio is increased in patients with rheumatic mitral valve stenosis?
por: Akboğa, Mehmet Kadri, et al.
Publicado: (2015)

Venous thromboembolic prophylaxis after simultaneous bilateral total knee arthroplasty: aspirin versus warfarin
por: Goel, R., et al.
Publicado: (2018)

Warfarin-Induced Skin Necrosis
por: Kakagia, Despoina D., et al.
Publicado: (2014)

Warfarin induced skin necrosis
por: Sahu, Kamal Kant, et al.
Publicado: (2016)

Ethnic Diversity and Warfarin Pharmacogenomics
por: Asiimwe, Innocent G., et al.
Publicado: (2022)

Is the use of warfarin becoming obsolete?
por: Haykal, Tarek, et al.
Publicado: (2021)

Warfarin: Bleeding: case report
Publicado: (2021)

Peri-procedural interrupted oral anticoagulation for atrial fibrillation ablation: comparison of aspirin, warfarin, dabigatran, and rivaroxaban
por: Winkle, Roger A., et al.
Publicado: (2014)

The effect of the VKORC1 promoter variant on warfarin responsiveness in the Saudi WArfarin Pharmacogenetic (SWAP) cohort
por: Al Ammari, Maha, et al.
Publicado: (2020)

Influence of Vitamin D Status on the Maintenance Dose of Warfarin in Patients Receiving Chronic Warfarin Therapy
por: Khansari, Nakisa, et al.
Publicado: (2022)

Evaluation of Bleeding Rate and Time in Therapeutic Range in Patients Using Warfarin Before and During the COVID-19 Pandemic—Warfarin Treatment in COVID-19
por: Emren, Zeynep Yapan, et al.
Publicado: (2021)

Risk of Gastrointestinal Bleeding with Rivaroxaban: A Comparative Study with Warfarin
por: Sherid, Muhammed, et al.
Publicado: (2016)

Chronic Subdural Hematoma in Elderly Patient with EDTA-dependent Pseudothrombocytopenia Recently Treated with Aspirin and Warfarin: Case Report
por: TOSA, Masato, et al.
Publicado: (2014)

Successful Treatment of Livedoid Vasculitis with Primary Antiphospholipid Syndrome by Using Aspirin and Low Dose Warfarin Combination Therapy
por: So, Byoung Joon, et al.
Publicado: (2015)

Effect of warfarin versus aspirin on blood viscosity in cardioembolic stroke with atrial fibrillation: a prospective clinical trial
por: Lee, Chan-Hyuk, et al.
Publicado: (2019)

The use of warfarin in veterans with atrial fibrillation
por: Bravata, Dawn M, et al.
Publicado: (2004)

Systematic Review of Pharmacogenetic Warfarin Dosing
por: van Schie, Rianne M. F., et al.
Publicado: (2009)

Warfarin-Induced Eosinophilic Pleural Effusion
por: Jo, Yong-Min, et al.
Publicado: (2011)

Effect of age and sex on warfarin dosing
por: Khoury, Ghada, et al.
Publicado: (2014)

Dental extraction in patients on warfarin treatment
por: Abdullah, Walid Ahmed, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_nga48p0br4l60a7hb85bmp3sli